| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.019 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |